Inhibition of Astrocyte-Derived Neurotoxic Lipid for Treatment of Neurological Injury and Diseases
Efficacious treatment for chronic neurological diseases and acute central nervous system (CNS) injury.
First-in-Class Vaccine Platform to Halt Prion Transmission Across Species
A first-in-class vaccine approach to prevent or delay fatal, transmissible prion diseases in humans and animals.
Innovative IGF-2 Receptor Agonists for Treating Neurodevelopmental Disorders and Neurodegenerative Diseases
Disease-modifying therapy with differentiated mechanisms of action to restore memory and motor function in neurodegenerative diseases and neurodevelopmental disorders.
Enhancing Neuronal Resistance to Neurodegeneration
Novel therapeutic approach to reverse or prevent the progression of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
A Biomarker for Cerebral Amyloid Angiopathy (CAA) and Amyloid Related Imaging Abnormality Risk
A biofluid biomarker to reliably diagnose Cerebral Amyloid Angiopathy (CAA) and predict the risk of Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer’s disease patients.
Modulating Neuron and Oligodendrocyte Survival by Targeting Astrocyte-Secreted Neurotoxic Lipids and Lipoproteins
Hydrophobically Interspaced, Charged Peptides for the Treatment and Prevention of Dementia
An Innovative and efficacious therapeutic strategy to prevent and/or treat AD and other dementias.